Correlation Between Nutriband and Alnylam Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Nutriband and Alnylam Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nutriband and Alnylam Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Nutriband and Alnylam Pharmaceuticals, you can compare the effects of market volatilities on Nutriband and Alnylam Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nutriband with a short position of Alnylam Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nutriband and Alnylam Pharmaceuticals.

Diversification Opportunities for Nutriband and Alnylam Pharmaceuticals

0.42

Correlation Coefficient

Nutriband  Alnylam Pharmaceuticals

Very weak diversification

The 3 months correlation between Nutriband and Alnylam is 0.42. Overlapping area represents the amount of risk that can be diversified away by holding Nutriband and Alnylam Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Alnylam Pharmaceuticals and Nutriband is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nutriband are associated (or correlated) with Alnylam Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Alnylam Pharmaceuticals has no effect on the direction of Nutriband i.e., Nutriband and Alnylam Pharmaceuticals go up and down completely randomly.

Pair Corralation between Nutriband and Alnylam Pharmaceuticals

Given the investment horizon of 90 days Nutriband is expected to generate 3.21 times more return on investment than Alnylam Pharmaceuticals. However, Nutriband is 3.21 times more volatile than Alnylam Pharmaceuticals. It trades about 0.11 of its potential returns per unit of risk. Alnylam Pharmaceuticals is currently generating about 0.01 per unit of risk. If you would invest  235.00  in Nutriband on March 18, 2024 and sell it today you would earn a total of  301.00  from holding Nutriband or generate 128.09% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Nutriband  vs.  Alnylam Pharmaceuticals

Nutriband

Risk-Adjusted Performance

16 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Nutriband are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Nutriband sustained solid returns over the last few months and may actually be approaching a breakup point.

Alnylam Pharmaceuticals

Risk-Adjusted Performance

7 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Alnylam Pharmaceuticals are ranked lower than 7 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unsteady basic indicators, Alnylam Pharmaceuticals may actually be approaching a critical reversion point that can send shares even higher in July 2024.

Pair Trading with Nutriband and Alnylam Pharmaceuticals

The main advantage of trading using opposite Nutriband and Alnylam Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nutriband position performs unexpectedly, Alnylam Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Alnylam Pharmaceuticals will offset losses from the drop in Alnylam Pharmaceuticals' long position.

The idea behind Nutriband and Alnylam Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.